Rating
Hold
Price target
$100
Previous
$90
Implied upside
+32%

Goldman Sachs analyst James Schneider raised the price target on Marvell Technology (NASDAQ: MRVL) to $100.00 (from $90.00) while maintaining a Neutral rating.

“We expect the stock to trade higher following stronger 1Q guidance and a continued constructive outlook for Marvell’s Datacenter ramp, which is driving improving long-term visibility for the business.

Marvell increased its CY27 Datacenter revenue guidance to 50% YoY growth (up from 40% YoY), with custom compute revenue growing 100% YoY.

At the overall company level, management expects to drive 40% revenue growth in CY27 while driving over $5.00 in non-GAAP earnings power – which we see as a significant positive.

Overall, we view Marvell’s results as an incremental medium-term positive for the stock given increased visibility into medium-term fundamentals.

We are Neutral on the stock given lower visibility into the expansion of Marvell’s custom silicon customer base relative to peers, but could consider being more constructive if we gain incremental confidence in the company’s custom compute revenue ramp in CY27 and beyond.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.